Back to Journals » OncoTargets and Therapy » Volume 9

Review

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

       
Total article views   HTML views PDF downloads Totals
15,356 Dovepress* 10,509+ 1,597 12,106
PubMed Central* 4,847 1,105 5,952
Totals 15,356 2,702 18,058
*Since 20 October 2016

View citations on PubMed Central and Google Scholar